Log in to save to my catalogue

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal canc...

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal canc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2393583424

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer

About this item

Full title

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer

Publisher

Athens: Spandidos Publications UK Ltd

Journal title

International journal of oncology, 2020-06, Vol.56 (6), p.1529-1539

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications UK Ltd

More information

Scope and Contents

Contents

Dual specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) is a protein kinase that functions as a novel tumor suppressor. Previous studies have reported that DYRK2 expression is decreased in colorectal cancer compared with adjacent non-tumor tissues. However, the regulatory mechanisms by which the expression of DYRK2 is diminished remain...

Alternative Titles

Full title

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2393583424

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2393583424

Other Identifiers

ISSN

1019-6439

E-ISSN

1791-2423

DOI

10.3892/ijo.2020.5020

How to access this item